legal Archives

First Opinion Anand Parekh

Preventive services can improve Americans’ health, but they are now on trial

Business Tara Bannow

UnitedHealth bid for Change Healthcare may proceed, judge rules

Pharmalot Ed Silverman

Pfizer accused of running a fellowship program that discriminates on racial grounds

Health Care Inc. Bob Herman

Raising a RUC-kus, Blues’ antitrust deal appealed, & a UAE deal

Insurance Bob Herman

Home Depot, other employers appeal Blue Cross Blue Shield antitrust settlement

Health Nicholas Florko

Advocates wanted Juul’s big settlement to overhaul the e-cigarette landscape. It likely won’t, experts warn

Insurance Bob Herman

Judge invalidates parts of the ACA that mandate health coverage of many preventive services and drugs

Pharmalot Ed Silverman

Pharma donations to patient charities may violate the ‘spirit’ of anti-kickback laws

Pharmalot Ed Silverman

Bayer agrees to $40 million settlement over kickbacks and downplaying drug safety risks

Pharma Tara Bannow

In a new lawsuit, pharma-backed patient groups fight federal rule around copay coupons

Pharmalot Ed Silverman

Pharmalittle: Moderna sues Pfizer over Covid-19 vax patents; White House directs quick access to federally funded research

Health Associated Press

Judge rules CVS, Walgreens, and Walmart owe $650M in opioids suit

First Opinion Antonio Dajer, Christie Lech and Lucy Willis

Medical error: An epidemic compounded by gag laws

Health Trisha Pasricha

Pregnancy tests are routine before many surgical procedures. But Dobbs has raised the stakes of a positive result

First Opinion Mandeep Dhaliwal

Decriminalizing HIV: Scientifically proven and morally correct

A STAT Investigation Jared Whitlock

Nursing home chain’s tangled corporate structure and bankruptcy threats stymied litigation

Pharmalot Ed Silverman

Pharmalittle: U.S. government blunder contributed to monkeypox vax shortage; Amgen to pay $4 billion for ChemoCentryx

Pharmalot Ed Silverman

Lilly is ordered to pay $61 million for shortchanging the Medicaid drug rebate program

Pharmalot Ed Silverman

U.S. appeals court panel decides AbbVie’s ‘patent thickets’ for Humira don’t thwart competition

Pharma Geoff Mulvihill — Associated Press

Drugmaker Teva latest to settle opioid lawsuits nationally

Pharmalot Ed Silverman

Pfizer loses another court battle alleging the U.S. illegally limits use of copay assistance programs

First Opinion Reuben Guttman and Liza Vertinsky

Demanding more impact from impact litigation: lessons to be learned from multi-state opioid settlements

Pharmalot Ed Silverman

Biogen agrees to pay $900 million to settle whistleblower case alleging kickbacks and sham speaking events

Pharmalot Ed Silverman

Contract research organization to transfer 4,000 beagles from facility cited for inhumane care

Pharmalot Ed Silverman

legal

Most Read

Sacklers agree to $6 billion Purdue bankruptcy settlement over opioid crisis

Inappropriate march-in actions would jeopardize public-private partnerships that make lifesaving medicines possible

In a defamation lawsuit, the hype around digital health clashes with scientific criticism

3 burning questions spurred by the big CRISPR patent ruling

Supreme Court debates exactly when a doctor’s misprescribing becomes criminal

Tennessee judge sanctions Endo for withholding opioid documents, refuses to recuse himself from case

UC Berkeley loses CRISPR patent case, invalidating patent rights it granted gene-editing companies developing human therapies

Johnson & Johnson, three pharma wholesalers finalize $26 billion opioid crisis settlement

All Coverage

Preventive services can improve Americans’ health, but they are now on trial

UnitedHealth bid for Change Healthcare may proceed, judge rules

Pfizer accused of running a fellowship program that discriminates on racial grounds

Raising a RUC-kus, Blues’ antitrust deal appealed, & a UAE deal

Home Depot, other employers appeal Blue Cross Blue Shield antitrust settlement

Advocates wanted Juul’s big settlement to overhaul the e-cigarette landscape. It likely won’t, experts warn

Judge invalidates parts of the ACA that mandate health coverage of many preventive services and drugs

Pharma donations to patient charities may violate the ‘spirit’ of anti-kickback laws

Bayer agrees to $40 million settlement over kickbacks and downplaying drug safety risks

In a new lawsuit, pharma-backed patient groups fight federal rule around copay coupons

Pharmalittle: Moderna sues Pfizer over Covid-19 vax patents; White House directs quick access to federally funded research

Judge rules CVS, Walgreens, and Walmart owe $650M in opioids suit

Medical error: An epidemic compounded by gag laws

Pregnancy tests are routine before many surgical procedures. But Dobbs has raised the stakes of a positive result

Decriminalizing HIV: Scientifically proven and morally correct

Nursing home chain’s tangled corporate structure and bankruptcy threats stymied litigation

Pharmalittle: U.S. government blunder contributed to monkeypox vax shortage; Amgen to pay $4 billion for ChemoCentryx

Lilly is ordered to pay $61 million for shortchanging the Medicaid drug rebate program

U.S. appeals court panel decides AbbVie’s ‘patent thickets’ for Humira don’t thwart competition

Drugmaker Teva latest to settle opioid lawsuits nationally

Pfizer loses another court battle alleging the U.S. illegally limits use of copay assistance programs

Demanding more impact from impact litigation: lessons to be learned from multi-state opioid settlements

Biogen agrees to pay $900 million to settle whistleblower case alleging kickbacks and sham speaking events

Contract research organization to transfer 4,000 beagles from facility cited for inhumane care

A Supreme Court review of a contentious patent issue would change the way pharma claims discoveries

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day